Hørslev-Petersen K - Search Results

1

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response.

Kragstrup TW, Jalilian B, Keller KK, Zhang X, Laustsen JK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hauge EM, Hvid M, Vorup-Jensen T, Deleuran B. Kragstrup TW, et al. PLoS One. 2016 Feb 5;11(2):e0148486. doi: 10.1371/journal.pone.0148486. eCollection 2016. PLoS One. 2016. PMID: 26849368 Free PMC article. Clinical Trial.

2

Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.

Hasselbalch H, Junker P, Hørslev-Petersen K, Lisse I, Bentsen KD. Hasselbalch H, et al. Am J Hematol. 1990 Jan;33(1):18-26. doi: 10.1002/ajh.2830330105. Am J Hematol. 1990. PMID: 2293759

3

Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.

Hørslev-Petersen K, Bentsen KD, Halberg P, Junker P, Kivirikko KI, Majamaa K, Risteli L, Risteli J, Lorenzen I. Hørslev-Petersen K, et al. Clin Exp Rheumatol. 1988 Apr-Jun;6(2):129-34. Clin Exp Rheumatol. 1988. PMID: 2846219

4

The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.

Hørslev-Petersen K, Saxne T, Haar D, Thomsen BS, Bentsen KD, Junker P, Lorenzen I. Hørslev-Petersen K, et al. Rheumatol Int. 1988;8(1):1-9. doi: 10.1007/BF00541343. Rheumatol Int. 1988. PMID: 3259005

5

Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.

Hørslev-Petersen K, Ammitzbøll T, Engström-Laurent A, Bentsen K, Junker P, Asboe-Hansen G, Lorenzen I. Hørslev-Petersen K, et al. J Rheumatol. 1988 Mar;15(3):460-7. J Rheumatol. 1988. PMID: 3259985

6

Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.

Hørslev-Petersen K, Bentsen KD, Junker P, Mathiesen FK, Hansen TM, Lorenzen I. Hørslev-Petersen K, et al. Clin Rheumatol. 1988 Mar;7(1):61-8. doi: 10.1007/BF02284058. Clin Rheumatol. 1988. PMID: 3261674

7

Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Hørslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I. Hørslev-Petersen K, et al. Ann Rheum Dis. 1988 Feb;47(2):116-26. doi: 10.1136/ard.47.2.116. Ann Rheum Dis. 1988. PMID: 3355249 Free PMC article.

8

Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions.

Hørslev-Petersen K, Bentsen KD, Junker P, Lorenzen I. Hørslev-Petersen K, et al. Arthritis Rheum. 1986 May;29(5):592-9. doi: 10.1002/art.1780290503. Arthritis Rheum. 1986. PMID: 3718552

9

[Procollagen peptide in the serum of patients with rheumatoid arthritis and liver diseases].

Bentsen KD, Hørslev-Petersen K, Horn T, Junker P. Bentsen KD, et al. Ugeskr Laeger. 1986 Aug 4;148(32):2011-4. Ugeskr Laeger. 1986. PMID: 3750528 Danish. No abstract available.

10

Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.

Johansen JS, Stoltenberg M, Hansen M, Florescu A, Hørslev-Petersen K, Lorenzen I, Price PA. Johansen JS, et al. Rheumatology (Oxford). 1999 Jul;38(7):618-26. doi: 10.1093/rheumatology/38.7.618. Rheumatology (Oxford). 1999. PMID: 10461474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page